In summary, FXR is downregulated in both mouse and human models of CRC when the tissues are progressing from normal intestinal epithelia to dysplastic lesions, indicating a therapeutic and/or diagnostic potential for these transcription factors in CRC. Here, NR1H4 is linked to colorectal carcinoma.